Clinical Trials Search Results
Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)
- AFT 25 Comet
Comparison Of Operative To Monitoring And Endocrine Therapy (Comet) Trial For Low Risk Dcis: A Phase Iii Prospective Randomized Trial
- Alliance A011401
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer.
- Alliance A011502
A randomized phase III double blinded placebo-controlled trial of aspirin as adjuvant therapy for node-positive, HER2 negative breast cancer.
- Alliance A021502 (Atomic)
Testing the addition of the antibody atezolizumab to usual chemotherapy after surgery in patients with colon cancer
- Alliance A151216
Genetic Testing For Patients with Resectable or Resected Lung Cancer
- Alliance A211601
Evaluation of Mammographic Breast Density Effect of Aspirin: A companion study to Alliance Study A011502
- CCCWFU 97116
A Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil in Chemotherapy Exposed Breast Cancer Survivors with Cognitive Impairment
- CCCWFU 97415 (Upbeat)
Understanding and Predicting Breast Cancer Events after Treatment (UPBEAT).
- CTSU EA5142
Nivolumab after Surgery and Chemotherapy in Treating Patients with Stage IB-IIIA Non-small Cell Lung Cancer